The hierarchy of different treatments for myogenous temporomandibular disorders: a systematic review and network meta-analysis of randomized clinical trials.

Oral and maxillofacial surgery Pub Date : 2022-12-01 Epub Date: 2021-10-21 DOI:10.1007/s10006-021-01009-y
Essam Ahmed Al-Moraissi, Paulo César Rodrigues Conti, Abdulmalik Alyahya, Khaled Alkebsi, Ahmed Elsharkawy, Nikolaos Christidis
{"title":"The hierarchy of different treatments for myogenous temporomandibular disorders: a systematic review and network meta-analysis of randomized clinical trials.","authors":"Essam Ahmed Al-Moraissi,&nbsp;Paulo César Rodrigues Conti,&nbsp;Abdulmalik Alyahya,&nbsp;Khaled Alkebsi,&nbsp;Ahmed Elsharkawy,&nbsp;Nikolaos Christidis","doi":"10.1007/s10006-021-01009-y","DOIUrl":null,"url":null,"abstract":"<p><p>The best treatment modality for the management of painful temporomandibular disorders of muscular origin (M-TMD) with predictable outcomes based on solid evidence is still not well defined. Thus, the aim of this network meta-analysis (NMA) was to identify the best treatment for adult patients with M-TMD. An electronic search was undertaken from the inception of each database to August 2018, to identify randomized clinical trials (RCTs), which are comparing two or more of the following treatment modalities in patients with M-TMD: counseling therapy; occlusal appliances; manual therapy; laser therapy; dry needling; intramuscular injection of local anesthesia (LA) or botulinum toxin-A (BTX-A); muscle relaxants; hypnosis/relaxation therapy; oxidative ozone therapy; and placebo or no treatment. Primary outcome variables were the reduction of pain and mechanical sensitivity. The secondary outcome was the maximal mouth opening (MMO). The quality of evidence was rated according to Cochrane's tool for assessing risk of bias. Standardized mean difference was used to analyze via frequentist network meta-analysis (NMA), using STATA software. 52 RCTs were included in this NMA. At the most follow up moments, manual therapy, counseling therapy, occlusal splints therapy, and needling using BTX-A or LA as well as dry needling significantly decreased post-treatment pain intensity in M-TMDs, when compared to placebo.  At short term (≤5 months), the four highest-ranked treatments for post-treatment pain reduction were manual therapy (83.5%, low quality evidence), ozone therapy (75.7%, very low quality evidence),counseling  therapy (71.2%, moderate quality), and occlusal appliances  (71.7%,moderate quality evidence). When intermediate term (≥6 months)was considered, BTX-A (85.8%, very low quality evidence) , counseling therapy(80%, low quality evidence), occlusal appliances  (62.8%, low quality evidence) and hypnosis (50.6%, very low quality evidence) were the four highest-ranked treatments.  This NMA reveals that manual therapy can be considered the most effective treatment for M-TMD, followed by counseling treatment, intramuscular injection of LA, and occlusal appliances  . However, considering the limitations of the studies included, and the scarce of strong evidence, the present findings should be interpreted cautiously.</p>","PeriodicalId":520733,"journal":{"name":"Oral and maxillofacial surgery","volume":" ","pages":"519-533"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral and maxillofacial surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10006-021-01009-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

The best treatment modality for the management of painful temporomandibular disorders of muscular origin (M-TMD) with predictable outcomes based on solid evidence is still not well defined. Thus, the aim of this network meta-analysis (NMA) was to identify the best treatment for adult patients with M-TMD. An electronic search was undertaken from the inception of each database to August 2018, to identify randomized clinical trials (RCTs), which are comparing two or more of the following treatment modalities in patients with M-TMD: counseling therapy; occlusal appliances; manual therapy; laser therapy; dry needling; intramuscular injection of local anesthesia (LA) or botulinum toxin-A (BTX-A); muscle relaxants; hypnosis/relaxation therapy; oxidative ozone therapy; and placebo or no treatment. Primary outcome variables were the reduction of pain and mechanical sensitivity. The secondary outcome was the maximal mouth opening (MMO). The quality of evidence was rated according to Cochrane's tool for assessing risk of bias. Standardized mean difference was used to analyze via frequentist network meta-analysis (NMA), using STATA software. 52 RCTs were included in this NMA. At the most follow up moments, manual therapy, counseling therapy, occlusal splints therapy, and needling using BTX-A or LA as well as dry needling significantly decreased post-treatment pain intensity in M-TMDs, when compared to placebo.  At short term (≤5 months), the four highest-ranked treatments for post-treatment pain reduction were manual therapy (83.5%, low quality evidence), ozone therapy (75.7%, very low quality evidence),counseling  therapy (71.2%, moderate quality), and occlusal appliances  (71.7%,moderate quality evidence). When intermediate term (≥6 months)was considered, BTX-A (85.8%, very low quality evidence) , counseling therapy(80%, low quality evidence), occlusal appliances  (62.8%, low quality evidence) and hypnosis (50.6%, very low quality evidence) were the four highest-ranked treatments.  This NMA reveals that manual therapy can be considered the most effective treatment for M-TMD, followed by counseling treatment, intramuscular injection of LA, and occlusal appliances  . However, considering the limitations of the studies included, and the scarce of strong evidence, the present findings should be interpreted cautiously.

肌源性颞下颌紊乱的不同治疗层次:随机临床试验的系统回顾和网络荟萃分析。
肌源性疼痛颞下颌关节疾病(M-TMD)的最佳治疗方式和可预测的结果基于确凿的证据仍然没有很好地定义。因此,本网络荟萃分析(NMA)的目的是确定成人M-TMD患者的最佳治疗方法。从每个数据库建立之初到2018年8月,进行了电子检索,以确定随机临床试验(rct),这些试验比较了M-TMD患者的两种或两种以上治疗方式:咨询治疗;咬合的电器;手动疗法;激光治疗;干针刺;肌内注射局麻(LA)或肉毒毒素a (BTX-A);肌肉松弛剂;催眠/放松疗法;氧化臭氧疗法;安慰剂或不治疗。主要结局变量为疼痛减轻和机械敏感性。次要观察指标为最大开口(MMO)。证据的质量是根据Cochrane的评估偏倚风险的工具来评定的。标准化均差采用频率网络元分析(NMA),采用STATA软件进行分析。本NMA共纳入52项随机对照试验。在大多数随访时刻,与安慰剂相比,手工治疗、咨询治疗、咬合夹板治疗、使用BTX-A或LA针刺以及干针刺可显著降低M-TMDs治疗后的疼痛强度。在短期(≤5个月),治疗后疼痛减轻排名最高的四种治疗方法是手工治疗(83.5%,低质量证据)、臭氧治疗(75.7%,极低质量证据)、咨询治疗(71.2%,中等质量证据)和咬合器具(71.7%,中等质量证据)。当考虑中期(≥6个月)时,BTX-A(85.8%,极低质量证据)、咨询治疗(80%,低质量证据)、咬合器具(62.8%,低质量证据)和催眠(50.6%,极低质量证据)是排名最高的四种治疗方法。该NMA显示,手工治疗可以被认为是M-TMD最有效的治疗方法,其次是咨询治疗、肌内注射LA和咬合器具。然而,考虑到所纳入研究的局限性,以及缺乏强有力的证据,本研究结果应谨慎解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信